🇺🇸 FDA
Patent

US 8946205

1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

granted A61KA61K31/437A61K31/444

Quick answer

US patent 8946205 (1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors) held by Addex Pharma, S.A. expires Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Addex Pharma, S.A.
Grant date
Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/437, A61K31/444, A61K31/553, A61K45/06